(Q30988464)

English

Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 June 2017

1 reference

Europe PubMed Central

Critical review of oral drug treatments for diabetic neuropathic pain-clinical outcomes based on efficacy and safety data from placebo-controlled and direct comparative studies (English)

1 reference

Europe PubMed Central

28 June 2017

0 references

neuropathic pain

0 references

Chantal Mathieu

3

object named as

Chantal Mathieu

1 reference

Europe PubMed Central

28 June 2017

author name string

Hugo Adriaensen

1

1 reference

Europe PubMed Central

28 June 2017

Léon Plaghki

2

1 reference

Europe PubMed Central

28 June 2017

Alfred Joffroy

4

1 reference

Europe PubMed Central

28 June 2017

Kris Vissers

5

1 reference

Europe PubMed Central

28 June 2017

language of work or name

1 reference

based on heuristic

inferred from title

publication date

1 May 2005

1 reference

Europe PubMed Central

28 June 2017

Diabetes - Metabolism: Research and Reviews

1 reference

Europe PubMed Central

28 June 2017

21

1 reference

Europe PubMed Central

28 June 2017

3

1 reference

Europe PubMed Central

28 June 2017

231-240

1 reference

Europe PubMed Central

28 June 2017

Managing painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

Anticonvulsant drugs for management of pain: a systematic review.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

Clomipramine vs desipramine vs placebo in the treatment of diabetic neuropathy symptoms. A double-blind cross-over study.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

Double-blind randomized trial of tramadol for the treatment of the pain of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

Controlled-release oxycodone for pain in diabetic neuropathy: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

Lamotrigine reduces painful diabetic neuropathy: a randomized, controlled study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

High-dose oral dextromethorphan versus placebo in painful diabetic neuropathy and postherpetic neuralgia

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

Amitriptyline relieves diabetic neuropathy pain in patients with normal or depressed mood

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

Phenytoin in the treatment of diabetic symmetrical polyneuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

Anticonvulsants (antineuropathics) for neuropathic pain syndromes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

21 January 2018

Neuropathic pain: aetiology, symptoms, mechanisms, and management

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Investigation of peripheral neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

A highly successful and novel model for treatment of chronic painful diabetic peripheral neuropathy.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

The Prevalence of Diabetic Distal Sensory Neuropathy in an English Community

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

The epidemiology of diabetic neuropathy. Diabetic Cardiovascular Autonomic Neuropathy Multicenter Study Group

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. The Diabetes Control and Complications Trial Research Group

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Diabetic neuropathy: scope of the syndrome

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Antidepressants and anticonvulsants for diabetic neuropathy and postherpetic neuralgia: a quantitative systematic review

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of pharmacological treatments of neuropathic pain: an update and effect related to mechanism of drug action.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Effects of desipramine, amitriptyline, and fluoxetine on pain in diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

The selective serotonin reuptake inhibitor paroxetine is effective in the treatment of diabetic neuropathy symptoms

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy of desipramine in painful diabetic neuropathy: a placebo-controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

The selective serotonin reuptake inhibitor citalopram relieves the symptoms of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Tramadol relieves pain and allodynia in polyneuropathy: a randomised, double-blind, controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

200 mg daily of lamotrigine has no analgesic effect in neuropathic pain: a randomised, double-blind, placebo controlled trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Sodium valproate in the management of painful neuropathy in type 2 diabetes - a randomized placebo controlled study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin for the symptomatic treatment of painful neuropathy in patients with diabetes mellitus: a randomized controlled trial.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin in the treatment of painful diabetic neuropathy: a placebo controlled, double blind, crossover trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Mexiletine for treatment of chronic painful diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Efficacy and safety of mexiletine in the treatment of painful diabetic neuropathy. The Mexiletine Study Group

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Mexiletine in the treatment of diabetic neuropathy

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Acetyl-L-carnitine (levacecarnine) in the treatment of diabetic neuropathy. A long-term, randomised, double-blind, placebo-controlled study

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Randomized double-blind study comparing the efficacy of gabapentin with amitriptyline on diabetic peripheral neuropathy pain

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Ratio scales of sensory and affective verbal pain descriptors.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Peripheral diabetic neuropathy: current concepts in treatment

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Imipramine treatment in diabetic neuropathy: relief of subjective symptoms without changes in peripheral and autonomic nerve function

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Treatment options in postherpetic neuralgia.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Symptomatic treatment of peripheral diabetic neuropathy with carbamazepine (Tegretol�): Double blind crossover trial

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Studies on the mechanism of action of the novel anticonvulsant lamotrigine (Lamictal) using primary neurological cultures from rat cortex

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Effect of lamotrigine on the electrically-evoked release of endogenous amino acids from slices of dorsal horn of the rat spinal cord

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin use in neuropathic pain syndromes

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

The novel anticonvulsant drug, gabapentin (Neurontin), binds to the alpha2delta subunit of a calcium channel

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Gabapentin inhibits calcium currents in isolated rat brain neurons.

1 reference

https://api.crossref.org/works/10.1002%2FDMRR.552

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1002/DMRR.552

1 reference

Europe PubMed Central

28 June 2017

1 reference

Europe PubMed Central

28 June 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q30988464&oldid=1973850601"